Assessment of gait parameters and physical function in patients with advanced cancer participating in a 12-week exercise and nutrition programme: A controlled clinical trial

Nursing and Health Professions

• Body Composition 100%
• Inflammation 100%
• Advanced Cancer 100%
• Biosensor 50%
• Stride Length 50%
• Muscle Mass 50%
• Malignant Neoplasm 50%
• Wearables 50%
• Walking Speed 50%
• Cancer Staging 50%
• Functional Status 50%
• Six Minute Walk Test 50%
• Gait Analysis System 50%
• Blood Analysis 50%
• Grip Strength 50%
• Grip Strength Test 50%
• Walking Distance 50%
• Nutritional Support 50%
• Karnofsky Performance Status 50%

Medicine and Dentistry

• Advanced Cancer 100%
• Nutrition Program 100%
• Controlled Clinical Trial 100%
• Malignant Neoplasm 50%
• Functional Status 50%
• Walking Speed 50%
• Karnofsky Performance Status 50%
• Cancer Staging 50%
• Walking Distance 50%
• Blood Analysis 50%
• Nutritional Support 50%
• Bioelectrical Impedance Analysis 50%
• Nutrition 50%
• Skeletal Muscle 50%
• Six Minute Walk Test 50%

Keyphrases

• Whole-body Electromyostimulation 100%
• Parameter Function 100%
• Patients with Advanced Cancer 100%
• Advanced Cancer 66%
• Functional Decline 33%
• Physical Status 33%
• Blood Analysis 33%
• Emotional Functioning 33%
• Skeletal muscle Mass 33%
• Bioelectrical Impedance Analysis 33%
• Functional Status 33%
• 6-minute Walk Test (6MWT) 33%
• Combined Exercise Program 33%
• 6-minute Walk Distance (6MWD) 33%
• Handgrip Strength Test 33%
• EORTC QLQ-C30 33%